{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:06:03Z","timestamp":1791237963738,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2017457"],"award-info":[{"award-number":["A2017457"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peiyu Project of Meizhou People\u2019s Hospital","award":["PY-C2019004"],"award-info":[{"award-number":["PY-C2019004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10620-020-06260-z","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T02:26:06Z","timestamp":1587695166000},"page":"1110-1126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8640-2427","authenticated-orcid":false,"given":"Gao-Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Dong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"6260_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"6260_CR2","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1158\/0008-5472.CAN-19-0803","volume":"79","author":"M Yarchoan","year":"2019","unstructured":"Yarchoan M, Agarwal P, Villanueva A, et al. Recent developments and therapeutic strategies against hepatocellular carcinoma. Cancer Res. 2019;79:4326\u20134330.","journal-title":"Cancer Res"},{"key":"6260_CR3","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3748\/wjg.v25.i11.1366","volume":"25","author":"T Besheer","year":"2019","unstructured":"Besheer T, Elalfy H, El-Maksoud MA, et al. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus. World J Gastroenterol. 2019;25:1366\u20131377. https:\/\/doi.org\/10.3748\/wjg.v25.i11.1366.","journal-title":"World J Gastroenterol"},{"key":"6260_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5152\/tjg.2018.17570","volume":"29","author":"T Besheer","year":"2018","unstructured":"Besheer T, Arafa M, El-Maksoud MA, et al. Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: role of ABCB11 genotype polymorphism and plasma bile acid levels. Turk J Gastroenterol Off J Turk Soc Gastroenterol. 2018;29:299\u2013307. https:\/\/doi.org\/10.5152\/tjg.2018.17570.","journal-title":"Turk J Gastroenterol Off J Turk Soc Gastroenterol"},{"key":"6260_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/jir.2016.0111","volume":"37","author":"T Besheer","year":"2017","unstructured":"Besheer T, El-Bendary M, Elalfy H, et al. Prediction of fibrosis progression rate in patients with chronic hepatitis c genotype 4: role of cirrhosis risk score and host factors. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. 2017;37:97\u2013102. https:\/\/doi.org\/10.1089\/jir.2016.0111.","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"6260_CR6","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/jso.25738","volume":"120","author":"G Duininck","year":"2019","unstructured":"Duininck G, Lopez-Aguiar AG, Lee RM, et al. Optimizing cancer care for hepatocellular carcinoma at a safety-net hospital: the value of a multidisciplinary disease management team. J Surg Oncol.. 2019;120:1365\u20131370. https:\/\/doi.org\/10.1002\/jso.25738.","journal-title":"J Surg Oncol."},{"key":"6260_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156:477\u2013491. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.065.","journal-title":"Gastroenterology"},{"key":"6260_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-019-1099-7","volume":"18","author":"BB Hu","year":"2019","unstructured":"Hu BB, Wang XY, Gu XY, et al. N-methyladenosine (mA) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications. Mol Cancer. 2019;18:178. https:\/\/doi.org\/10.1186\/s12943-019-1099-7.","journal-title":"Mol Cancer"},{"key":"6260_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, et al. Recognition of RNA N-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u2013295.","journal-title":"Nat Cell Biol"},{"key":"6260_CR10","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169:1187\u20131200. https:\/\/doi.org\/10.1016\/j.cell.2017.05.045.","journal-title":"Cell"},{"key":"6260_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2019.1711324","author":"X Sui","year":"2020","unstructured":"Sui X, Hu Y, Ren C, et al. METTL3-mediated mA is required for murine oocyte maturation and maternal-to-zygotic transition. Cell Cycle (Georgetown, Tex). 2020;. https:\/\/doi.org\/10.1080\/15384101.2019.1711324.","journal-title":"Cell Cycle (Georgetown, Tex)"},{"key":"6260_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12943-019-1119-7","volume":"18","author":"L Liu","year":"2019","unstructured":"Liu L, Wang J, Sun G, et al. mA mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma. Mol Cancer.. 2019;18:188. https:\/\/doi.org\/10.1186\/s12943-019-1119-7.","journal-title":"Mol Cancer."},{"key":"6260_CR13","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1038\/s41467-018-06898-4","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Xie L, Wang M, et al. Mettl3-mediated mA RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9:4772. https:\/\/doi.org\/10.1038\/s41467-018-06898-4.","journal-title":"Nat Commun"},{"key":"6260_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.bbagrm.2019.06.008","volume":"1862","author":"R Wu","year":"2019","unstructured":"Wu R, Guo G, Bi Z, et al. mA methylation modulates adipogenesis through JAK2-STAT3-C\/EBP\u03b2 signaling. Biochim Biophys Acta Gene regul Mech. 2019;1862:796\u2013806. https:\/\/doi.org\/10.1016\/j.bbagrm.2019.06.008.","journal-title":"Biochim Biophys Acta Gene regul Mech"},{"key":"6260_CR15","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1002\/jcp.26507","volume":"233","author":"C Ding","year":"2018","unstructured":"Ding C, Zou Q, Ding J, et al. Increased N6-methyladenosine causes infertility is associated with FTO expression. J Cell Physiol. 2018;233:7055\u20137066. https:\/\/doi.org\/10.1002\/jcp.26507.","journal-title":"J Cell Physiol"},{"key":"6260_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11010-019-03641-5","volume":"463","author":"J Yu","year":"2020","unstructured":"Yu J, Shen L, Liu Y, et al. The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-\u03baB signaling. Mol Cell Biochem. 2020;463:203\u2013210. https:\/\/doi.org\/10.1007\/s11010-019-03641-5.","journal-title":"Mol Cell Biochem"},{"key":"6260_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/2159-8290.CD-18-0959","volume":"9","author":"LP Vu","year":"2019","unstructured":"Vu LP, Cheng Y, Kharas MG. The biology of mA RNA methylation in normal and malignant hematopoiesis. Cancer Discov. 2019;9:25\u201333.","journal-title":"Cancer Discov"},{"key":"6260_CR18","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, H\u00fcttelmaier S, Liu T. The critical role of RNA mA methylation in cancer. Cancer Res. 2019;79:1285\u20131292.","journal-title":"Cancer Res"},{"key":"6260_CR19","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77:e108.","journal-title":"Cancer Res"},{"key":"6260_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.cd-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.cd-12-0095.","journal-title":"Cancer Discov"},{"key":"6260_CR21","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"key":"6260_CR22","doi-asserted-by":"publisher","first-page":"D856","DOI":"10.1093\/nar\/gku1151","volume":"43","author":"WY Huang","year":"2015","unstructured":"Huang WY, Hsu SD, Huang HY, et al. MethHC: a database of DNA methylation and gene expression in human cancer. Nucleic Acids Res. 2015;43:D856\u2013D861. https:\/\/doi.org\/10.1093\/nar\/gku1151.","journal-title":"Nucleic Acids Res"},{"key":"6260_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur V, Iljasenko T, Metsalu T, Lokk K, Laisk-Podar T, Vilo J. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 2018;10:277\u2013288.","journal-title":"Epigenomics"},{"key":"6260_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/1471-2164-7-252","volume":"7","author":"I Diboun","year":"2006","unstructured":"Diboun I, Wernisch L, Orengo CA, Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics.. 2006;7:252. https:\/\/doi.org\/10.1186\/1471-2164-7-252.","journal-title":"BMC Genomics."},{"key":"6260_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00280-011-1810-x","volume":"69","author":"YS Yu","year":"2012","unstructured":"Yu YS, Tang ZH, Pan QC, Chen XH, Liu XN, Zang GQ. Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells. Cancer Chemother Pharmacol. 2012;69:1173\u20131180. https:\/\/doi.org\/10.1007\/s00280-011-1810-x.","journal-title":"Cancer Chemother Pharmacol"},{"key":"6260_CR26","doi-asserted-by":"publisher","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267. https:\/\/doi.org\/10.1038\/ng1180. https:\/\/www.nature.com\/articles\/ng1180#supplementary-information.","DOI":"10.1038\/ng1180"},{"key":"6260_CR27","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6260_CR28","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92\u2013D97.","journal-title":"Nucleic Acids Res"},{"key":"6260_CR29","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PloS ONE. 2018;13:e0206239.","journal-title":"PloS ONE"},{"key":"6260_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.07.012","author":"M Xu","year":"2019","unstructured":"Xu M, Zhen L, Lin L, Wu K, Wang Y, Cai X. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2019;. https:\/\/doi.org\/10.1016\/j.clinre.2019.07.012.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"6260_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/onc.2012.618","volume":"33","author":"X You","year":"2014","unstructured":"You X, Liu F, Zhang T, et al. Hepatitis B virus X protein upregulates Lin28A\/Lin28B through Sp-1\/c-Myc to enhance the proliferation of hepatoma cells. Oncogene. 2014;33:449\u2013460. https:\/\/doi.org\/10.1038\/onc.2012.618.","journal-title":"Oncogene"},{"key":"6260_CR32","first-page":"2736","volume":"23","author":"ZY Wang","year":"2017","unstructured":"Wang ZY, Yang J, Liu CK, Shen SQ. High expression of retinoblastoma-binding protein 2 (RBP2) in patients with hepatocellular carcinoma and its prognostic significance. Med Sci Monit Int Med J Exp Clin Res. 2017;23:2736\u20132744.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"6260_CR33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1159\/000487353","volume":"45","author":"H Zhu","year":"2018","unstructured":"Zhu H, Wang J, Yin J, et al. Downregulation of PRAME suppresses proliferation and promotes apoptosis in hepatocellular carcinoma through the activation of P53 mediated pathway. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2018;45:1121\u20131135. https:\/\/doi.org\/10.1159\/000487353.","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"6260_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.4103\/jcrt.JCRT_491_17","volume":"13","author":"J Chen","year":"2017","unstructured":"Chen J, Li S, Zhou S, et al. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma. J Cancer Res Ther. 2017;13:651\u2013659. https:\/\/doi.org\/10.4103\/jcrt.JCRT_491_17.","journal-title":"J Cancer Res Ther"},{"key":"6260_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/thno.28992","volume":"9","author":"YL Zheng","year":"2019","unstructured":"Zheng YL, Li L, Jia YX, et al. LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt\/mTOR signaling pathway. Theranostics. 2019;9:796\u2013810. https:\/\/doi.org\/10.7150\/thno.28992.","journal-title":"Theranostics"},{"key":"6260_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mc.22580","volume":"56","author":"Y Bai","year":"2017","unstructured":"Bai Y, Wang J, Han J, et al. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo. Mol Carcinog. 2017;56:1137\u20131149. https:\/\/doi.org\/10.1002\/mc.22580.","journal-title":"Mol Carcinog"},{"key":"6260_CR37","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41388-017-0057-3","volume":"37","author":"S Hua","year":"2018","unstructured":"Hua S, Lei L, Deng L, et al. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 2018;37:1624\u20131636. https:\/\/doi.org\/10.1038\/s41388-017-0057-3.","journal-title":"Oncogene"},{"key":"6260_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.03.034","author":"T Yin","year":"2019","unstructured":"Yin T, Liu MM, Jin RT, Kong J, Wang SH, Sun WB. miR-152-3p modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8. Pathol Res Pract. 2019;. https:\/\/doi.org\/10.1016\/j.prp.2019.03.034.","journal-title":"Pathol Res Pract"},{"key":"6260_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-019-0957-7","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang L, Chen T, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p\/FOXA1 axis. Mol Cancer. 2019;18:28. https:\/\/doi.org\/10.1186\/s12943-019-0957-7.","journal-title":"Mol Cancer"},{"key":"6260_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2019.03.012","author":"J Gao","year":"2019","unstructured":"Gao J, Yin X, Yu X, Dai C, Zhou F. Long noncoding RNA LINC00488 functions as a ceRNA to regulate hepatocellular carcinoma cell growth and angiogenesis through miR-330-5. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2019;. https:\/\/doi.org\/10.1016\/j.dld.2019.03.012.","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"6260_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28655","author":"J Ye","year":"2019","unstructured":"Ye J, Zhang J, Lv Y, et al. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. J Cell Biochem. 2019;. https:\/\/doi.org\/10.1002\/jcb.28655.","journal-title":"J Cell Biochem"},{"key":"6260_CR42","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.2147\/cmar.s191565","volume":"11","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Yin Z, Hou B, et al. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets. Cancer Manag Res. 2019;11:3921\u20133931. https:\/\/doi.org\/10.2147\/cmar.s191565.","journal-title":"Cancer Manag Res"},{"key":"6260_CR43","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1080\/15384101.2017.1380125","volume":"16","author":"J Chen","year":"2017","unstructured":"Chen J, Sun Y, Xu X, et al. YTH domain family 2 orchestrates epithelial-mesenchymal transition\/proliferation dichotomy in pancreatic cancer cells. Cell Cycle (Georgetown, Tex).. 2017;16:2259\u20132271. https:\/\/doi.org\/10.1080\/15384101.2017.1380125.","journal-title":"Cell Cycle (Georgetown, Tex)."},{"key":"6260_CR44","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.18632\/oncotarget.23365","volume":"9","author":"J Li","year":"2018","unstructured":"Li J, Meng S, Xu M, et al. Downregulation of N(6)-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N(6)-methyladenosine levels. Oncotarget. 2018;9:3752\u20133764. https:\/\/doi.org\/10.18632\/oncotarget.23365.","journal-title":"Oncotarget"},{"key":"6260_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2019.03.021","author":"J Paris","year":"2019","unstructured":"Paris J, Morgan M, Campos J, et al. Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell. 2019;. https:\/\/doi.org\/10.1016\/j.stem.2019.03.021.","journal-title":"Cell Stem Cell"},{"key":"6260_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","volume":"442","author":"L Zhong","year":"2019","unstructured":"Zhong L, Liao D, Zhang M, et al. YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma. Cancer Lett. 2019;442:252\u2013261. https:\/\/doi.org\/10.1016\/j.canlet.2018.11.006.","journal-title":"Cancer Lett"},{"key":"6260_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/2326-6066.CIR-17-0201","volume":"6","author":"JK Rhee","year":"2018","unstructured":"Rhee JK, Jung YC, Kim KR, et al. Impact of tumor purity on immune gene expression and clustering analyses across multiple cancer types. Cancer Immunol Res. 2018;6:87\u201397. https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0201.","journal-title":"Cancer Immunol Res"},{"key":"6260_CR48","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41467-019-09712-x","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Bai R, Li M, et al. Excessive miR-25-3p maturation via N(6)-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Nat Commun. 2019;10:1858. https:\/\/doi.org\/10.1038\/s41467-019-09712-x.","journal-title":"Nat Commun"},{"key":"6260_CR49","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3233\/cbm-170791","volume":"21","author":"X Zhao","year":"2018","unstructured":"Zhao X, Chen Y, Mao Q, et al. Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Biomark Sect A Dis Mark. 2018;21:859\u2013868. https:\/\/doi.org\/10.3233\/cbm-170791.","journal-title":"Cancer Biomark Sect A Dis Mark"},{"key":"6260_CR50","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u20132270. https:\/\/doi.org\/10.1002\/hep.29683.","journal-title":"Hepatology"},{"key":"6260_CR51","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41467-019-09865-9","volume":"10","author":"X Lin","year":"2019","unstructured":"Lin X, Chai G, Wu Y, et al. RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat Commun. 2019;10:2065. https:\/\/doi.org\/10.1038\/s41467-019-09865-9.","journal-title":"Nat Commun"},{"key":"6260_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory R. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:335\u2013345.","journal-title":"Mol Cell"},{"key":"6260_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control. Nature. 2017;552:126\u2013131. https:\/\/doi.org\/10.1038\/nature24678.","journal-title":"Nature"},{"key":"6260_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0755-0","author":"F Yang","year":"2019","unstructured":"Yang F, Jin H, Que B, et al. Dynamic m(6)A mRNA methylation reveals the role of METTL3-m(6)A-CDCP1 signaling axis in chemical carcinogenesis. Oncogene. 2019;. https:\/\/doi.org\/10.1038\/s41388-019-0755-0.","journal-title":"Oncogene"},{"key":"6260_CR55","doi-asserted-by":"publisher","first-page":"109403","DOI":"10.1016\/j.biopha.2019.109403","volume":"120","author":"J Mo","year":"2019","unstructured":"Mo J, Li B, Zhou Y, et al. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression. Biomed Pharmacother. 2019;120:109403. https:\/\/doi.org\/10.1016\/j.biopha.2019.109403.","journal-title":"Biomed Pharmacother"},{"key":"6260_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Xiao J, Bai J, et al. Molecular characterization and clinical relevance of mA regulators across 33 cancer types. Mol Cancer. 2019;18:137. https:\/\/doi.org\/10.1186\/s12943-019-1066-3.","journal-title":"Mol Cancer"},{"key":"6260_CR57","doi-asserted-by":"publisher","first-page":"8899","DOI":"10.1002\/jcp.27551","volume":"234","author":"D Zhu","year":"2019","unstructured":"Zhu D, Zhou J, Zhao J, et al. ZC3H13 suppresses colorectal cancer proliferation and invasion via inactivating Ras-ERK signaling. J Cell Physiol. 2019;234:8899\u20138907. https:\/\/doi.org\/10.1002\/jcp.27551.","journal-title":"J Cell Physiol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06260-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06260-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06260-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T01:29:46Z","timestamp":1619314186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06260-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6260"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06260-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"12 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data in this study were obtained from the TCGA database, and the data acquisition and application method complied with the corresponding database guidelines and policies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}